Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.
about
Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-AmericansEvaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteinsEffect of Synthetic Truncated Apolipoprotein C-I Peptide on Plasma Lipoprotein Cholesterol in Nonhuman PrimatesCardioprotective functions of HDLsMolecular mechanisms of cellular cholesterol effluxEffects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertensionABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic miceApolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distributionIn vivo biochemical and gene expression analyses of the antioxidant activities and hypocholesterolaemic properties of Tamarindus indica fruit pulp extractDramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibilityPrelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivoGenetic basis of lipoprotein disorders.Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanistiThe ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout miceDelayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiencySetting the course for apoAII: a port in sight?Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes.Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye diseaseOrphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter.Coincidence of genetic loci for plasma cholesterol levels and obesity in a multifactorial mouse model.Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distributionApolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.Brisk walking and serum lipid and lipoprotein variables in previously sedentary women--effect of 12 weeks of regular brisk walking followed by 12 weeks of detrainingThe role of risk factors in the development of atherosclerosis.High-density-lipoprotein cholesterol and atherosclerosis.Intraindividual variability of children's blood lipid and lipoprotein concentrations: a review.Effects of acute exercise on high density lipoprotein cholesterol and high density lipoprotein subfractions in moderately trained femalesEffects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgeneAnimal models of atherosclerosis.Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals.Lipid Variables Related to the Extent and Severity of Coronary Artery Disease in Non-Diabetic Turkish Cypriots.Antiatherogenic effects of the antioxidant BO-653 in three different animal models.Transgenic rabbit models for studying human cardiovascular diseases.Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells.The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generationRepression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acidA comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.
P2860
Q23911481-C99737FB-CB68-4ABD-88AD-77ABACB50D42Q24533539-448BED03-3EF8-47F6-8FA6-11D1F8BD241FQ24805786-240BE2B1-893D-4722-8E90-979C93F696BEQ27000421-D8C610A4-3F9F-47B0-8EBE-3D987CE2B353Q27021139-D8EF30F4-2ADA-4DDF-B91D-F348879C2C4CQ28333637-5DF1DF6B-E60F-47FF-9184-598C63C43295Q28344150-AFFEAA68-560E-48FE-AEE3-8EE74CF74653Q28513005-2AEEABE3-150C-4BB2-9B4D-AB4BF909BAF8Q28534816-30C4D933-DE5F-46F3-B708-EC5DF898226CQ28586230-6A7D896E-2D39-4A85-BA85-6B65A93DA0E1Q33589194-AED28066-F07C-4BC0-918F-869F4824733EQ33847743-7D5CCFCA-5EB9-4A8F-9F50-A4038E059A1FQ33896520-ADA09CBB-BF84-446C-801F-EB9DFDE304C1Q33897937-4BC79D0A-CC83-432C-B5A1-BB24D4BCD048Q33903940-7EA0DDCD-6B42-49E9-8463-957DF35EA6E7Q33939998-1E294BD8-9A24-4C87-AA5B-B3BA1597E36DQ33994790-84AC0F45-326C-48BF-9CF1-29CD2B2DFDB5Q34119817-53E5B8B9-6F66-472D-902C-AB4B88AFC26CQ34120460-78EA5831-4145-456B-B671-6AF1E2FD0516Q34129395-20560F0F-A493-4A6C-B931-4D4BE7B5E52FQ34170860-43BA536D-4307-4204-A65B-A5D748BDA509Q34186341-8D1E74D4-6040-4E19-8F14-CBEAE2DBBE00Q34229782-646CF127-6E7E-4B30-A0B8-033FDFC208DAQ34264245-7B50124E-AD59-42D9-B5DD-57906233B127Q34447107-15EA7B22-D488-49B4-8D9F-A49735B4444AQ34707124-283B7CED-C24C-4152-AB79-98817B43EA4CQ34714729-B4672998-5B41-4F91-AD3E-974554CF7907Q35556620-2681F8D3-B98B-45BD-B7AB-403B3490582FQ35590298-8AA2FEE7-9E23-49DF-8E7D-641104EC707AQ35605274-778C774F-1D6C-42CD-9193-453E62EC4BE3Q35765195-5F8192C0-7947-41F9-A355-FFD9A7BA7141Q35903298-1E967EE9-631B-4DB2-9823-2EB68381FA09Q36091141-3827F841-4077-4A85-84D9-7E3AAD09C0E9Q36282163-DE0D4EEA-99EF-471C-86F9-5231ADF4078EQ36286332-FAB50F05-9472-424D-A681-1157655577FFQ36481289-7B6E3B11-C63C-40CF-9271-C56C0808CF5BQ36683551-578708B2-7C87-49C2-B6C4-003FB43135A9Q36701853-04E619FA-7097-4B0F-90DE-9E4A916FBF0FQ36820868-AB8C2427-A11B-4209-A665-4C5B6F33B096Q36892261-99CF5F42-8E9C-4317-8B74-E259ACBAA2B2
P2860
Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Associations of high-density l ...... and coronary atherosclerosis.
@en
Associations of high-density l ...... and coronary atherosclerosis.
@nl
type
label
Associations of high-density l ...... and coronary atherosclerosis.
@en
Associations of high-density l ...... and coronary atherosclerosis.
@nl
prefLabel
Associations of high-density l ...... and coronary atherosclerosis.
@en
Associations of high-density l ...... and coronary atherosclerosis.
@nl
P1476
Associations of high-density l ...... and coronary atherosclerosis.
@en
P2093
P304
P356
10.1016/0002-8703(87)90638-7
P407
P433
P577
1987-02-01T00:00:00Z